Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.
03-Aug-2026
Download PDF
Jenburkt Pharma
Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.